208 related articles for article (PubMed ID: 31682640)
1. Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells.
Osada AH; Endo K; Kimura Y; Sakamoto K; Nakamura R; Sakamoto K; Ueki K; Yoshizawa K; Miyazawa K; Saitoh M
PLoS One; 2019; 14(11):e0217451. PubMed ID: 31682640
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
[TBL] [Abstract][Full Text] [Related]
3. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
4. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.
Shirakihara T; Horiguchi K; Miyazawa K; Ehata S; Shibata T; Morita I; Miyazono K; Saitoh M
EMBO J; 2011 Feb; 30(4):783-95. PubMed ID: 21224849
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
Marek L; Ware KE; Fritzsche A; Hercule P; Helton WR; Smith JE; McDermott LA; Coldren CD; Nemenoff RA; Merrick DT; Helfrich BA; Bunn PA; Heasley LE
Mol Pharmacol; 2009 Jan; 75(1):196-207. PubMed ID: 18849352
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression.
Horny K; Sproll C; Peiffer L; Furtmann F; Gerhardt P; Gravemeyer J; Stoecklein NH; Spassova I; Becker JC
J Transl Med; 2023 Apr; 21(1):267. PubMed ID: 37076857
[TBL] [Abstract][Full Text] [Related]
7. Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells.
Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):626-639. PubMed ID: 28930565
[TBL] [Abstract][Full Text] [Related]
8. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.
Ranieri D; Rosato B; Nanni M; Magenta A; Belleudi F; Torrisi MR
Oncotarget; 2016 Feb; 7(5):5440-60. PubMed ID: 26713601
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9.
Kettunen P; Karavanova I; Thesleff I
Dev Genet; 1998; 22(4):374-85. PubMed ID: 9664689
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma.
Maehara O; Suda G; Natsuizaka M; Ohnishi S; Komatsu Y; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Shimazaki T; Kimura M; Asano A; Fujimoto Y; Ohashi S; Kagawa S; Kinugasa H; Naganuma S; Whelan KA; Nakagawa H; Nakagawa K; Takeda H; Sakamoto N
Carcinogenesis; 2017 Oct; 38(11):1073-1083. PubMed ID: 28927233
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
12. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
[TBL] [Abstract][Full Text] [Related]
13. FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis.
Pirvola U; Spencer-Dene B; Xing-Qun L; Kettunen P; Thesleff I; Fritzsch B; Dickson C; Ylikoski J
J Neurosci; 2000 Aug; 20(16):6125-34. PubMed ID: 10934262
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor expression reflects cellular differentiation in human oral squamous carcinoma cell lines.
Drugan CS; Paterson IC; Prime SS
Carcinogenesis; 1998 Jun; 19(6):1153-6. PubMed ID: 9667757
[TBL] [Abstract][Full Text] [Related]
15. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
17. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
18. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.
Scotet E; Houssaint E
Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315
[TBL] [Abstract][Full Text] [Related]
19. Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.
Nakashima C; Kirita T; Yamamoto K; Mori S; Luo Y; Sasaki T; Fujii K; Ohmori H; Kawahara I; Mori T; Goto K; Kishi S; Fujiwara-Tani R; Kuniyasu H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998265
[TBL] [Abstract][Full Text] [Related]
20. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]